Regeneron drops after skin cancer treatment misses late-stage trial goal
Regeneron drops after skin cancer treatment misses late-stage trial goal
SOURCE →Articles tagged into the technology lens — led this volume by United States of America · United Kingdom · China · Russian Federation · Hong Kong Special Administrative Region of China.
Regeneron drops after skin cancer treatment misses late-stage trial goal
SOURCE →How Elon Musk and Sam Altman went from besties to bitter rivals
SOURCE →South Korea market volatility nears record high after $13 billion foreign investor selloff
SOURCE →What we know about the latest Ebola outbreak after WHO declares global health emergency
SOURCE →Four bystanders tackle knife-wielding driver after car plows into crowd in Italy
SOURCE →Top Wall Street analysts suggest these 3 stocks for their long-term prospects
SOURCE →A quantum computing deadline looms. It threatens to kick off the biggest cybersecurity crisis ever
SOURCE →South Korea says it will pursue all options to avoid Samsung strike
SOURCE →We traded our smartphones for flip phones for 4 days—and learned that ditching modern technology is harder than it sounds
SOURCE →Cerebras blockbuster IPO boosts hype for SpaceX and OpenAI, but crowds out smaller players
SOURCE →New Ebola outbreak in remote Congo province kills 80
SOURCE →Trump went big on tech stocks in first quarter of 2026, new filings show
SOURCE →Biggest bottleneck in the AI buildup fuels DRAM ETF to record
SOURCE →Chinese EVs are coming to Canada, and some dealers cant wait to sell them
SOURCE →Nvidias trillion-dollar run puts pressure on the bulls
SOURCE →Cerebras IPO, Trump-Xi summit takeaways, automaker layoffs and more in Morning Squawk
SOURCE →Detroit automakers have cut more than 20,000 U.S. salaried jobs as AI threat looms
SOURCE →He declared a new country governed by AI. He’s not sure it will end well
SOURCE →Bill Ackman built Microsoft stake in first quarter during selloff, betting on AI and cloud growth
SOURCE →Ackmans Pershing Square takes stake in Microsoft, citing compelling valuation
SOURCE →Honda shares rise over 7% as investors shrug off first operating loss in nearly 70 years
SOURCE →CNBC Daily Open: Trump-Xi summit delivers Wall Street boost
SOURCE →Closing arguments conclude in Musk v. Altman, jury to deliberate next week
SOURCE →South Korea’s Kospi retreats from record high to drop over 6% as heavyweight tech names sell-off
SOURCE →Stock futures pull back with Nasdaq-100 futures off 1% as tech trade cools: Live updates
SOURCE →Where Cerebras monster debut puts in among techs biggest IPOs
SOURCE →SpaceX IPO prospectus could land as soon as next week, sources say
SOURCE →Some short sellers are seeing opportunity in this tech mania. How theyre spotting fake AI stocks
SOURCE →Goldman says tech stock up crash is sign of even more gains to come
SOURCE →Cerebras pops 68% in Nasdaq debut, pushing the AI chipmakers market cap to $95 billion
SOURCE →